PRRT2 and renal cell carcinoma: Increased PKC activity has been noticed during the development and progression of RCC, and several PKC inhibitors have been found to decrease the invasiveness of aggressive human RCC cell lines, suggesting a proinvasive role for PKC in this context [170,171].